•
Dec 31, 2023
•
/

BioNTech SE Q4 2023 Earnings Report

Total Revenue
€1.47B
Previous year: €4.05B
-63.8%
EPS
€1.89
Previous year: €8.77
-78.5%
R&D Expenses
€578M
SG&A Expenses
€142M
Operating Profit
€526M
Gross Profit
€1.29B
Cash and Equivalents
€11.9B
Free Cash Flow
€1.05B
Total Assets
€23.4B

BioNTech SE

BioNTech SE

BioNTech SE Revenue by Segment